Skip to content

The effect of aromatherapy with essential oils of rose on blood pressure in patients with hypertension

The effect of aromatherapy with essential oils of rose on blood pressure in patients with hypertension Bahraman city of Rafsanjan in 2016

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017060422320N2
Enrollment
70
Registered
2017-10-03
Start date
2017-05-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension Incl.: High blood pressure

Interventions

Intervention 1: In the control group, sesame oil is filtered and odorless as a placebo. Patients are subjected to aromatherapy for 2 consecutive days for 2 minutes and for 2 weeks by inhalation, three
Placebo
In the control group, sesame oil is filtered and odorless as a placebo. Patients are subjected to aromatherapy for 2 consecutive days for 2 minutes and for 2 weeks by inhalation, three drops of placeb
In the aroma group, the essential oil of Mohammadi is diluted on the basis of filtered sesame oil, and is used as an additive. Patients in the aroma group undergo aromatherapy at a distance of 5 cm fr

Sponsors

Vice chancellor of Research, Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Major entry into the study includes the fact that blood pressure is detected by controlling the blood pressure recorded in the previous three periods; Having primary blood pressure; Having hypertension in stage 1 and 2; Healthy feeling; Not having sensitivity to the essential oil of the flower of Mohammadi and a history of allergies or respiratory diseases. The main outcomes of the study include the patient's reluctance to continue studying; Sensitization during the implementation of the plan; Lack of cooperation in referring to the health center for controlling blood pressure; Neuropsychiatric patients taking medication and illnesses that cause the patient to use drugs that alter blood pressure during research.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hypertension. Timepoint: Before the intervention, 2,5,9,12 days after, two days after intervention. Method of measurement: Blood pressure in millimeters of mercury using a digital blood pressure.

Secondary

MeasureTime frame
Pulse. Timepoint: Before the intervention, 2,5,9,12 days after, two days after completion of the intervention. Method of measurement: In terms of pulse rate using a digital blood pressure.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026